Production (Stage)
Aspire Biopharma Holdings, Inc.
ASBP
$0.225
$0.0010.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.94M | -738.50K | -243.60K | -- | -231.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.52M | -- | -- | -- | -- |
| Change in Net Operating Assets | -326.30K | 1.22M | -290.20K | -- | 38.00K |
| Cash from Operations | -1.75M | 479.60K | -533.80K | -- | -193.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 38.30K | -- | -- |
| Cash from Investing | -- | -- | 38.30K | -- | -- |
| Total Debt Issued | 3.05M | -492.50K | 492.50K | -- | -- |
| Total Debt Repaid | -221.40K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | -- | 229.10K |
| Repurchase of Common Stock | -- | -257.60K | -- | -- | -- |
| Issuance of Preferred Stock | -- | 257.60K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 265.80K | -- | -- | -- | -- |
| Cash from Financing | 3.09M | -492.50K | 492.50K | -- | 229.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.34M | -12.90K | -3.10K | -- | 36.10K |